Recent

% | $
Quotes you view appear here for quick access.

Rosetta Genomics, Ltd. Message Board

  • kiksbutt kiksbutt Dec 7, 2012 10:24 PM Flag

    Also, FYI, a shelf offering can be done to prevent a hostile takeover

    While their after hours release was strategically planned from a business standpoint, and a good one too, I think we might have a nice pump PR on Monday morning.

    Nevertheless, if nothing comes soon, news will come in January. They can't dilute at these levels and they won't. They're trading at book value since they got 30 mil in cash, enough to fund 2 years of operations. I think something big is brewing here.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Posion pill, that was another explaination presented after the 35 million shelf offering in June when the PPS was trading at $11. They finally diluted at $5 only 5 weeks later. Now they want $75 million. Do you really think they won't dilute at these prices given their past? I think this makes 6 dilutions within a year.

 
ROSG
0.88-0.06(-6.38%)Sep 27 3:59 PMEDT